CKD Progression: interpreting guidelines through the lens of recent data; CKD and RAASi optimisation

2023-02-17に共有
Supported by an unrestricted educational grant by AstraZeneca

Speaker
Philip Kalra, United Kingdom

Panellist
Sunil Bhandari, United Kingdom

Moderator
Smeeta Sinha, United Kingdom

コメント (3)